JWLLF.US Jamieson Wellness Inc
- Market cap
- USD 1.33B
- P/E
- 24.2x
- P/B
- 3.73x
- ROE
- 10.5%
- Dividend yield
- 2.24%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is JWLLF.US undervalued?
Graham numberJWLLF.US trades 100.3% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Jamieson Wellness Inc fundamental analysis
No fundamental analysis for Jamieson Wellness Inc yet.
Jamieson Wellness Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Jamieson Wellness Inc
Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells the natural health products for human in Canada, the United States, China, and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products, including vitamins, minerals, and supplements as well as sports nutrition products. The Strat…
Full company profileJamieson Wellness Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Jamieson Wellness Inc annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 248M | 301M | 320M | 345M | 404M | 451M | 547M | 676M | 734M | 821M | 808M |
| Gross Profit | 80.8M | 105M | 115M | 130M | 145M | 162M | 198M | 234M | 276M | 338M | 333M |
| Operating Income | 31.0M | 44.9M | 50.1M | 55.4M | 63.6M | 76.0M | 83.2M | 87.4M | 106M | 114M | 87.7M |
| EBITDA | 38.6M | -6.89M | 56.2M | 66.4M | 75.3M | 94.2M | 100M | 109M | 115M | 133M | 109M |
| Net Income | -25.2M | -23.8M | 26.7M | 31.7M | 41.6M | 52.1M | 52.8M | 47.9M | 51.9M | 62.4M | 53.6M |
| EPS | -0.67 | -0.60 | 0.67 | 0.80 | 1.01 | 1.25 | 1.25 | 1.12 | 1.21 | 1.45 | 1.25 |
| Balance Sheet | |||||||||||
| Total Assets | 405M | 513M | 549M | 562M | 609M | 652M | 1.11B | 1.14B | 1.21B | 1.21B | 1.23B |
| Total Liabilities | 557M | 292M | 308M | 303M | 317M | 310M | 676M | 662M | 660M | 685M | 678M |
| Shareholders' Equity | -152M | 221M | 241M | 259M | 292M | 342M | 432M | 439M | 505M | 485M | 510M |
| Cash & Short-term Investments | 15.9M | 4.83M | 12.4M | 198K | 1.17M | 6.78M | 26.2M | 40.2M | 44.8M | 41.2M | 24.3M |
| Total Debt | 260M | 163M | 166M | 165M | 149M | 149M | 400M | 325M | 308M | 472M | 478M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 29.0M | 17.8M | 27.8M | 16.4M | 40.6M | 44.4M | 50.6M | 31.7M | 61.6M | 82.4M | -8.01M |
| Capital Expenditure | 4.71M | 4.99M | 11.5M | 9.50M | 13.2M | 22.3M | 14.6M | 9.31M | 10.2M | 12.7M | 9.14M |
| Free Cash Flow | 24.3M | 12.9M | 16.3M | 6.90M | 27.4M | 22.1M | 36.0M | 22.4M | 51.4M | 69.7M | -17.2M |
| Ratios | |||||||||||
| ROE | - | -10.8% | 11.1% | 12.2% | 14.2% | 15.2% | 12.2% | 10.9% | 10.3% | 12.9% | 10.5% |
| ROA | -6.2% | -4.6% | 4.9% | 5.6% | 6.8% | 8.0% | 4.8% | 4.2% | 4.3% | 5.1% | 4.3% |
| Net Profit Margin | -10.1% | -7.9% | 8.3% | 9.2% | 10.3% | 11.5% | 9.6% | 7.1% | 7.1% | 7.6% | 6.6% |
| Debt to Equity | - | 0.74x | 0.69x | 0.64x | 0.51x | 0.44x | 0.93x | 0.74x | 0.61x | 0.97x | 0.94x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Jamieson Wellness Inc dividends
- Dividend yield
- 2.24%
- Forward dividend
- 0.72 USD
- Payout ratio
- 59.6%
- Ex-dividend date
- Aug 31, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CAD 37.2M | 0.87 | 59.6% |
| 2024 | CAD 33.5M | 0.78 | 64.5% |
| 2023 | CAD 30.3M | 0.71 | 63.2% |
| 2022 | CAD 26.3M | 0.63 | 49.8% |
| 2021 | USD 22.1M | 0.53 | 42.4% |
| 2020 | USD 18.6M | 0.45 | 44.8% |
| 2019 | USD 14.7M | 0.37 | 46.4% |
| 2018 | USD 12.9M | 0.33 | 48.5% |
| 2017 | CAD 15.6M | 0.39 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Jamieson Wellness Inc
- Insiders 0.24%
- Institutions 37.10%
- Public & others 62.66%
- Shares outstanding 41.5M
- Free float 41.1M
Jamieson Wellness Inc company profile
- Company name
- Jamieson Wellness Inc
- Ticker
- JWLLF.US
- Exchange
- USA Stocks
- Sector
- Consumer Defensive
- Industry
- Food Products
- Fiscal year end
- December
- Address
- 1 Adelaide Street East, Toronto, ON, Canada, M5C 2V9
- Phone
- 800 265 5088
- Website
- jamiesonwellness.com
About Jamieson Wellness Inc
Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells the natural health products for human in Canada, the United States, China, and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products, including vitamins, minerals, and supplements as well as sports nutrition products. The Strategic Partners segment provides contract manufacturing services to consumer health companies and retailers. It offers health and wellness supplements under the Jamieson brand; health, beauty, and wellness supplements under the Youtheory brand; and foundational formulas, including probiotics, multivitamins, fish oils, vitamin D, and solution-focused products for better sleep or digestion under the Progressive brand. The company also provides plant-based products under the Iron Vegan brand; natural health products for health concerns among women comprising hormone imbalances, nutrient deficiencies, sleep and stress management, and others under the Smart Solutions brand; and sports nutrition supplements under the Precision brand. It sells its products to distributors, retail, and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.
Jamieson Wellness Inc management
10- Mr. Michael PilatoPresident, CEO & Director · born 1975
- Mr. Christopher Snowden CPAChief Financial Officer
- Ms. Regan StewartChief Operating Officer
- Mr. John DohertyChief Science & Innovation Officer · born 1973
- Ms. Ruth WinkerVice President of Corporate Affairs & Investor Relations
- Ms. Tara MartinSenior VP, General Counsel & Corporate Secretary
- Mr. Eric BentzExecutive VP of Global Marketing & MD of Canada
- Ms. Nicole StuartSenior Vice President of People & Culture
- Mr. Paul GalbraithExecutive VP & MD of USA
- Mr. Joel ScalesExecutive VP and MD of Jamieson International & Global Strategy